I read on another website that the Lucanix phase 3 trial has failed. Anyone know if this is true?
I would expect to see some results about this trial by around this time, but I haven't seen or heard anything through the usual academic channels. However, these results often trickle in through the financial news, sad to say. I've tried Google, the company's website, and twitter, and I'm not finding any recent news. Perhaps they're referring to the START trial with Stimuvax (see http://cancergrace.org/lung/2013/01/09/start-trial-fails/), which was just recently reported as negative for a survival benefit -- or else it's just a rumor that might be substantiated in upcoming news.
Dr. Howard (Jack) West
Associate Clinical Professor
City of Hope Cancer Center
Founder & President
Global Resource for Advancing
I suspect it emanates from this discussion on Inspire, which in turn was prompted by a patient's email from his or her oncologist at UCLA:
Obviously, we still need to learn things from official channels, but it's quite a development that lung cancer specialists are learning news about lung cancer treatments from patient group sides. I'd like some validating information, but it sounds like the chatter is right and that we'll probably get an official declaration of futility in 4 days. I suspect that the average patient on Inspire or GRACE knows more about ROS1 than their oncologist, and this is another example of patients knowing more than almost any doctor because the crowdsourcing of information.
Thanks for the tip, CS, disappointing though it is.